logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9763881 B1

PDFFull Text
Date of Patent:
Sep. 19, 2017

Filed:

Jun. 11, 2013

Rice bran-lipids based formulation and process for preparation thereof for selective delivery of genes to cancer cells

Applicant:

Council of Scientific and Industrial Research, New Delhi, IN;

Inventors:

Sayantani Roy, Hyderabad, IN;

Rajkumar Banerjee, Hyderabad, IN;

Pradosh Prasad Chakrabarti, Hyderabad, IN;

Badari Narayana Prasad Rachapudi, Hyderabad, IN;

Assignee:

COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH, New Delhi, IN;

Attorney:

Brinks Gilson & Lione

Primary Examiner:

Robert M Kelly

Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61K 38/19 (2006.01); A61K 38/45 (2006.01); A61K 38/50 (2006.01); A61K 47/44 (2017.01); A61K 47/24 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/127 (2013.01); A61K 9/1272 (2013.01); A61K 9/1277 (2013.01); A61K 38/1758 (2013.01); A61K 38/1841 (2013.01); A61K 38/191 (2013.01); A61K 38/45 (2013.01); A61K 38/50 (2013.01); A61K 47/44 (2013.01); A61K 47/24 (2013.01); A61K 48/00 (2013.01);
Abstract

The present invention relates to a formulation in which glycolipids and phospholipids, isolated from rice bran gum samples, were used in conjunction with gene carrying lipids to test its efficacy in delivering genes to cancer cells selectively. This formulation did not mediate efficient delivery of genes to non-cancerous cells, thus, showing potential use of this formulation to deliver anticancer therapeutics to cancer cells without eliciting treatment related toxicity to normal cells.

Find Patent Forward Citations

Loading…